TMO logo

Thermo Fisher Scientific (TMO) Cash from financing

annual CFF:

-$6.79B-$3.17B(-87.52%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TMO annual cash flow from financing activities is -$6.79 billion, with the most recent change of -$3.17 billion (-87.52%) on December 31, 2024.
  • During the last 3 years, TMO annual CFF has fallen by -$13.37 billion (-203.21%).
  • TMO annual CFF is now -203.21% below its all-time high of $6.58 billion, reached on December 31, 2021.

Performance

TMO Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOcash flow metrics

quarterly CFF:

-$102.00M+$3.56B(+97.22%)
March 29, 2025

Summary

  • As of today (May 29, 2025), TMO quarterly cash flow from financing activities is -$102.00 million, with the most recent change of +$3.56 billion (+97.22%) on March 29, 2025.
  • Over the past year, TMO quarterly CFF has increased by +$1.72 billion (+94.40%).
  • TMO quarterly CFF is now -101.20% below its all-time high of $8.47 billion, reached on December 31, 2021.

Performance

TMO quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOcash flow metrics

TTM CFF:

-$5.07B+$1.72B(+25.31%)
March 29, 2025

Summary

  • As of today (May 29, 2025), TMO TTM cash flow from financing activities is -$5.07 billion, with the most recent change of +$1.72 billion (+25.31%) on March 29, 2025.
  • Over the past year, TMO TTM CFF has dropped by -$2.22 billion (-78.00%).
  • TMO TTM CFF is now -146.23% below its all-time high of $10.97 billion, reached on March 29, 2014.

Performance

TMO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTMOcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TMO Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-87.5%+94.4%-78.0%
3 y3 years-203.2%+96.8%-161.2%
5 y5 years-117.8%-116.5%-372.4%

TMO Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-203.2%at low-104.3%+97.2%-161.2%+25.3%
5 y5-year-203.2%at low-101.2%+97.9%-161.2%+25.3%
alltimeall time-203.2%at low-101.2%+97.9%-146.2%+25.3%

TMO Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$102.00M(-97.2%)
-$5.07B(-25.3%)
Dec 2024
-$6.79B(+87.5%)
-$3.67B(+208.1%)
-$6.79B(+49.1%)
Sep 2024
-
-$1.19B(+934.8%)
-$4.55B(+201.8%)
Jun 2024
-
-$115.00M(-93.7%)
-$1.51B(-47.1%)
Mar 2024
-
-$1.82B(+27.5%)
-$2.85B(-21.3%)
Dec 2023
-$3.62B(+28.9%)
-$1.43B(-177.0%)
-$3.62B(-1938.6%)
Sep 2023
-
$1.85B(-227.4%)
$197.00M(-110.9%)
Jun 2023
-
-$1.46B(-43.8%)
-$1.81B(-19.9%)
Mar 2023
-
-$2.59B(-208.4%)
-$2.26B(-19.6%)
Dec 2022
-$2.81B(-142.7%)
$2.39B(-1683.4%)
-$2.81B(-186.0%)
Sep 2022
-
-$151.00M(-92.1%)
$3.27B(-49.4%)
Jun 2022
-
-$1.91B(-39.4%)
$6.46B(-22.1%)
Mar 2022
-
-$3.15B(-137.1%)
$8.29B(+25.9%)
Dec 2021
$6.58B(+586.2%)
$8.47B(+178.5%)
$6.58B(-440.1%)
Sep 2021
-
$3.04B(-4100.0%)
-$1.94B(-66.4%)
Jun 2021
-
-$76.00M(-98.4%)
-$5.77B(+27.8%)
Mar 2021
-
-$4.85B(+9798.0%)
-$4.51B(-570.3%)
Dec 2020
$959.00M(-130.8%)
-$49.00M(-93.8%)
$959.00M(+94.1%)
Sep 2020
-
-$791.00M(-167.0%)
$494.00M(-184.6%)
Jun 2020
-
$1.18B(+90.6%)
-$584.00M(-45.6%)
Mar 2020
-
$619.00M(-220.4%)
-$1.07B(-65.6%)
Dec 2019
-$3.12B(+39.4%)
-$514.00M(-72.5%)
-$3.12B(+19.1%)
Sep 2019
-
-$1.87B(-370.9%)
-$2.62B(+61.1%)
Jun 2019
-
$690.00M(-148.4%)
-$1.62B(-51.1%)
Mar 2019
-
-$1.43B(>+9900.0%)
-$3.32B(+48.4%)
Dec 2018
-$2.24B(-158.0%)
-$13.00M(-98.5%)
-$2.24B(-33.6%)
Sep 2018
-
-$876.00M(-12.9%)
-$3.37B(-193.8%)
Jun 2018
-
-$1.01B(+194.2%)
$3.59B(-1.2%)
Mar 2018
-
-$342.00M(-70.1%)
$3.63B(-5.8%)
Dec 2017
$3.85B(+39.7%)
-$1.14B(-118.8%)
$3.85B(+37.3%)
Sep 2017
-
$6.08B(-730.8%)
$2.81B(+94.0%)
Jun 2017
-
-$964.00M(+710.1%)
$1.45B(-3.4%)
Mar 2017
-
-$119.00M(-94.6%)
$1.50B(-45.7%)
Dec 2016
$2.76B(-205.4%)
-$2.19B(-146.4%)
$2.76B(-32.4%)
Sep 2016
-
$4.72B(-616.9%)
$4.08B(-379.7%)
Jun 2016
-
-$913.30M(-179.9%)
-$1.46B(+6.1%)
Mar 2016
-
$1.14B(-231.3%)
-$1.37B(-47.5%)
Dec 2015
-$2.62B(-154.6%)
-$869.90M(+6.4%)
-$2.62B(+57.9%)
Sep 2015
-
-$817.80M(-1.3%)
-$1.66B(-15.2%)
Jun 2015
-
-$828.90M(+725.6%)
-$1.95B(-33.5%)
Mar 2015
-
-$100.40M(-212.4%)
-$2.94B(-161.3%)
Dec 2014
$4.80B(+44.9%)
$89.30M(-108.0%)
$4.80B(-40.3%)
Sep 2014
-
-$1.11B(-38.6%)
$8.03B(-12.0%)
Jun 2014
-
-$1.81B(-123.8%)
$9.13B(-16.8%)
Mar 2014
-
$7.64B(+129.7%)
$10.97B(+231.5%)
Dec 2013
$3.31B(-460.7%)
$3.32B(<-9900.0%)
$3.31B(-633.1%)
Sep 2013
-
-$15.60M(-152.2%)
-$620.90M(+1232.4%)
Jun 2013
-
$29.90M(-207.6%)
-$46.60M(-87.1%)
Mar 2013
-
-$27.80M(-95.4%)
-$360.50M(-60.7%)
Dec 2012
-$917.70M(-125.8%)
-$607.40M(-208.7%)
-$917.70M(+21.3%)
Sep 2012
-
$558.70M(-296.7%)
-$756.70M(-148.6%)
Jun 2012
-
-$284.00M(-51.5%)
$1.56B(+18.4%)
Mar 2012
-
-$585.00M(+31.0%)
$1.31B(-63.0%)
Dec 2011
$3.55B(-374.2%)
-$446.40M(-115.5%)
$3.55B(-3.4%)
Sep 2011
-
$2.87B(-646.2%)
$3.67B(+1039.5%)
Jun 2011
-
-$525.70M(-131.8%)
$322.50M(-39.7%)
Mar 2011
-
$1.65B(-612.9%)
$534.50M(-141.3%)
Dec 2010
-$1.30B(+132.3%)
-$322.00M(-33.1%)
-$1.30B(+15.1%)
Sep 2010
-
-$481.30M(+53.4%)
-$1.13B(+72.5%)
Jun 2010
-
-$313.70M(+76.1%)
-$652.30M(-12.5%)
Mar 2010
-
-$178.10M(+16.9%)
-$745.40M(+33.7%)
Dec 2009
-$557.50M(+144.1%)
-$152.40M(+1781.5%)
-$557.50M(-8.8%)
Sep 2009
-
-$8.10M(-98.0%)
-$611.40M(+7.4%)
Jun 2009
-
-$406.80M(-4251.0%)
-$569.10M(+277.1%)
Mar 2009
-
$9.80M(-104.8%)
-$150.90M(-33.9%)
Dec 2008
-$228.40M(-75.4%)
-$206.30M(-703.2%)
-$228.40M(-27.6%)
Sep 2008
-
$34.20M(+200.0%)
-$315.30M(-58.8%)
Jun 2008
-
$11.40M(-116.8%)
-$764.40M(-4.7%)
Mar 2008
-
-$67.70M(-76.9%)
-$802.30M(-13.6%)
Dec 2007
-$928.70M
-$293.20M(-29.3%)
-$928.70M(+46.6%)
Sep 2007
-
-$414.90M(+1465.7%)
-$633.60M(+99.9%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$26.50M(-86.3%)
-$316.98M(-26.9%)
Mar 2007
-
-$194.10M(<-9900.0%)
-$433.71M(+66.7%)
Dec 2006
-$260.10M(-166.5%)
$1.90M(-101.9%)
-$260.10M(-11.3%)
Sep 2006
-
-$98.29M(-31.4%)
-$293.26M(+19.2%)
Jun 2006
-
-$143.23M(+599.1%)
-$246.01M(-167.0%)
Mar 2006
-
-$20.49M(-34.5%)
$367.11M(-6.1%)
Dec 2005
$390.86M(-313.3%)
-$31.27M(-38.7%)
$390.86M(-10.5%)
Sep 2005
-
-$51.03M(-110.9%)
$436.93M(+28.7%)
Jun 2005
-
$469.89M(>+9900.0%)
$339.62M(-304.2%)
Mar 2005
-
$3.27M(-77.9%)
-$166.35M(-9.2%)
Dec 2004
-$183.22M(-72.4%)
$14.80M(-110.0%)
-$183.22M(+11.8%)
Sep 2004
-
-$148.34M(+311.1%)
-$163.86M(-19.7%)
Jun 2004
-
-$36.09M(+165.3%)
-$203.95M(-49.0%)
Mar 2004
-
-$13.60M(-139.8%)
-$399.54M(-39.8%)
Dec 2003
-$663.63M(+11.9%)
$34.17M(-118.1%)
-$663.63M(-20.1%)
Sep 2003
-
-$188.43M(-18.7%)
-$830.83M(+4.8%)
Jun 2003
-
-$231.68M(-16.6%)
-$792.53M(+14.5%)
Mar 2003
-
-$277.69M(+108.7%)
-$691.97M(+16.7%)
Dec 2002
-$592.97M(-14.8%)
-$133.03M(-11.4%)
-$592.97M(-12.8%)
Sep 2002
-
-$150.13M(+14.5%)
-$680.13M(-22.3%)
Jun 2002
-
-$131.12M(-26.6%)
-$874.97M(+2.0%)
Mar 2002
-
-$178.69M(-18.9%)
-$857.71M(+23.2%)
Dec 2001
-$696.31M(+406.1%)
-$220.19M(-36.2%)
-$696.31M(+55.3%)
Sep 2001
-
-$344.97M(+203.0%)
-$448.31M(+274.2%)
Jun 2001
-
-$113.86M(+558.4%)
-$119.82M(-21.1%)
Mar 2001
-
-$17.29M(-162.2%)
-$151.90M(+10.4%)
Dec 2000
-$137.58M(-34.6%)
$27.81M(-268.8%)
-$137.58M(+46.4%)
Sep 2000
-
-$16.48M(-88.7%)
-$94.01M(-51.1%)
Jun 2000
-
-$145.94M(+4803.9%)
-$192.22M(+8.6%)
Mar 2000
-
-$2.98M(-104.2%)
-$177.02M(-15.8%)
Dec 1999
-$210.30M(-197.0%)
$71.39M(-162.2%)
-$210.30M(+11.0%)
Sep 1999
-
-$114.69M(-12.3%)
-$189.39M(-56.3%)
Jun 1999
-
-$130.74M(+260.6%)
-$433.80M(+531.8%)
Mar 1999
-
-$36.26M(-139.3%)
-$68.66M(-131.7%)
Dec 1998
$216.90M(+1.8%)
$92.30M(-125.7%)
$216.90M(+73.4%)
Sep 1998
-
-$359.10M(-253.2%)
$125.10M(-81.6%)
Jun 1998
-
$234.40M(-6.0%)
$679.30M(+44.7%)
Mar 1998
-
$249.30M(>+9900.0%)
$469.60M(+120.4%)
Dec 1997
$213.10M(-79.5%)
$500.00K(-99.7%)
$213.10M(-32.6%)
Sep 1997
-
$195.10M(+689.9%)
$316.20M(+100.3%)
Jun 1997
-
$24.70M(-443.1%)
$157.90M(-59.8%)
Mar 1997
-
-$7.20M(-106.9%)
$392.30M(-62.2%)
Dec 1996
$1.04B(+294.4%)
$103.60M(+181.5%)
$1.04B(+1.0%)
Sep 1996
-
$36.80M(-85.8%)
$1.03B(-8.5%)
Jun 1996
-
$259.10M(-59.4%)
$1.12B(+24.8%)
Mar 1996
-
$638.50M(+582.2%)
$900.30M(+242.1%)
Dec 1995
$263.20M(-12.5%)
$93.60M(-29.1%)
$263.20M(+77.5%)
Sep 1995
-
$132.10M(+265.9%)
$148.30M(+1529.7%)
Jun 1995
-
$36.10M(+2478.6%)
$9.10M(-96.7%)
Mar 1995
-
$1.40M(-106.6%)
$275.90M(-8.3%)
Dec 1994
$300.90M(-26.8%)
-$21.30M(+200.0%)
$300.90M(-20.5%)
Sep 1994
-
-$7.10M(-102.3%)
$378.40M(-45.9%)
Jun 1994
-
$302.90M(+1047.3%)
$699.00M(+71.0%)
Mar 1994
-
$26.40M(-53.0%)
$408.70M(-0.6%)
Dec 1993
$411.10M(-1.6%)
$56.20M(-82.1%)
$411.10M(+5.1%)
Sep 1993
-
$313.50M(+2388.1%)
$391.20M(+31.9%)
Jun 1993
-
$12.60M(-56.3%)
$296.50M(-28.3%)
Mar 1993
-
$28.80M(-20.7%)
$413.70M(-1.0%)
Dec 1992
$417.70M(+54.4%)
$36.30M(-83.4%)
$417.70M(-7.0%)
Sep 1992
-
$218.80M(+68.6%)
$449.10M(+38.0%)
Jun 1992
-
$129.80M(+295.7%)
$325.50M(+45.3%)
Mar 1992
-
$32.80M(-51.6%)
$224.00M(-17.2%)
Dec 1991
$270.60M(+256.5%)
$67.70M(-28.9%)
$270.60M(+25.5%)
Sep 1991
-
$95.20M(+236.4%)
$215.70M(+50.7%)
Jun 1991
-
$28.30M(-64.4%)
$143.10M(-9.5%)
Mar 1991
-
$79.40M(+520.3%)
$158.10M(+108.3%)
Dec 1990
$75.90M(-13.0%)
$12.80M(-43.4%)
$75.90M(+20.3%)
Sep 1990
-
$22.60M(-47.8%)
$63.10M(+55.8%)
Jun 1990
-
$43.30M(-1646.4%)
$40.50M(-1546.4%)
Mar 1990
-
-$2.80M
-$2.80M
Dec 1989
$87.20M
-
-

FAQ

  • What is Thermo Fisher Scientific annual cash flow from financing activities?
  • What is the all time high annual CFF for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific annual CFF year-on-year change?
  • What is Thermo Fisher Scientific quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific quarterly CFF year-on-year change?
  • What is Thermo Fisher Scientific TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Thermo Fisher Scientific?
  • What is Thermo Fisher Scientific TTM CFF year-on-year change?

What is Thermo Fisher Scientific annual cash flow from financing activities?

The current annual CFF of TMO is -$6.79B

What is the all time high annual CFF for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high annual cash flow from financing activities is $6.58B

What is Thermo Fisher Scientific annual CFF year-on-year change?

Over the past year, TMO annual cash flow from financing activities has changed by -$3.17B (-87.52%)

What is Thermo Fisher Scientific quarterly cash flow from financing activities?

The current quarterly CFF of TMO is -$102.00M

What is the all time high quarterly CFF for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high quarterly cash flow from financing activities is $8.47B

What is Thermo Fisher Scientific quarterly CFF year-on-year change?

Over the past year, TMO quarterly cash flow from financing activities has changed by +$1.72B (+94.40%)

What is Thermo Fisher Scientific TTM cash flow from financing activities?

The current TTM CFF of TMO is -$5.07B

What is the all time high TTM CFF for Thermo Fisher Scientific?

Thermo Fisher Scientific all-time high TTM cash flow from financing activities is $10.97B

What is Thermo Fisher Scientific TTM CFF year-on-year change?

Over the past year, TMO TTM cash flow from financing activities has changed by -$2.22B (-78.00%)
On this page